Marrone Bio Innovations Inc (MBII)

Sector:
MATERIALS
Industry:
CHEMICALS
SIC:
AGRICULTURAL CHEMICALS
CEO:
Kevin R. Helash
Employees:
150
1540 DREW AVENUE, DAVIS, CA 95618
530-750-2800

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin and Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality.

Data derived from most recent annual or quarterly report
Market Cap 145.538 Million Shares Outstanding182.378 Million Avg 30-day Volume 1.445 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.04
Price to Revenue4.4383 Debt to Equity1.4876 EBITDA-14.497 Million
Price to Book Value8.6098 Operating Margin-43.7242 Enterprise Value221.587 Million
Current Ratio0.79 EPS Growth0 Quick Ratio0.515
1 Yr BETA 0.8354 52-week High/Low 1.55 / 0.55 Profit Margin-47.0802
Operating Cash Flow Growth9.1528 Altman Z-Score-4.8747 Free Cash Flow to Firm -13.921 Million
View SEC Filings from MBII instead.

View recent insider trading info

Funds Holding MBII (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MBII

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-07-13:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-11:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-30:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-19:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-10:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-01-18:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MOORE LINDA V CHIEF LEGAL OFFICER

    • Officer
    0 2022-07-12 3

    OSPRAIE AG SCIENCE LLC

    OSPRAIE MANAGEMENT, LLC

    ANDERSON DWIGHT

    OSPRAIE HOLDING I, L.P.

    OSPRAIE MANAGEMENT, INC.

    • Director
    • 10% Owner
    • (SEE REMARKS)(SEE REMARKS)(SEE REMARKS)(SEE REMARKS)(SEE REMARKS)
    0 2022-07-12 2

    PITTS KEITH SVP & CHIEF SUST. OFFICER

    • Officer
    0 2022-07-12 3

    MARRONE PAMELA G

    • Director
    0 2022-07-12 6

    VASAVADA AMIT SVP & CTO

    • Officer
    0 2022-07-12 3

    JOHNSON TIMOTHY B VP (FIELD AND TECHNICAL)

    • Officer
    0 2022-07-12 3

    WOCHOK ZACHARY S.

    • Director
    0 2022-07-12 3

    WOODS ROBERT A

    • Director
    0 2022-07-12 3

    MAGO YOGESH

    • Director
    0 2022-07-12 3

    MCGOVERN KEITH

    • Director
    0 2022-07-12 3

    HELASH KEVIN CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    0 2022-07-12 3

    LEE LARA L

    • Director
    0 2022-07-12 3

    TIAINEN MATTI SVP, INTERNATIONAL SALES

    • Officer
    0 2022-07-12 1

    WOOLF STUART

    • Director
    11,000 2022-06-30 2

    JOHNSON LADON INTERIM CFO

    • Officer
    0 2022-03-10 1

    CHEUNG SUPING (SUE) CHIEF FINANCIAL OFFICER

    • Officer
    250,619 2022-02-07 2

    ARDSLEY ADVISORY PARTNERS LP

    ARDSLEY ADVISORY PARTNERS GP LLC

    ARDSLEY PARTNERS I GP LLC

    HEMPLEMAN PHILIP J

    ARDSLEY PARTNERS RENEWABLE ENERGY FUND, L.P.

    ARDSLEY PARTNERS FUND II, L.P.

    ARDSLEY PARTNERS ADVANCED HEALTHCARE FUND, L.P.

    • 10% Owner
    • SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)
    18,335,767 2021-11-11 0

    ARDSLEY ADVISORY PARTNERS LP

    ARDSLEY PARTNERS I GP LLC

    HEMPLEMAN PHILIP J

    ARDSLEY PARTNERS RENEWABLE ENERGY FUND, L.P.

    ARDSLEY RIDGECREST PARTNERS FUND, L.P.

    • 10% Owner
    • SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)
    17,717,753 2021-10-04 0

    HAMMILL KEVIN AUSTIN CHIEF MANUFACTURING AND SUPPLY

    • Officer
    77,315 2021-04-02 0

    BOYD JAMES PRESIDENT AND CFO

    • Officer
    309,291 2021-01-29 0

    ARDSLEY ADVISORY PARTNERS LP

    ARDSLEY ADVISORY PARTNERS GP LLC

    ARDSLEY PARTNERS I GP LLC

    HEMPLEMAN PHILIP J

    ARDSLEY PARTNERS RENEWABLE ENERGY FUND, L.P.

    ARDSLEY PARTNERS FUND II, L.P.

    ARDSLEY PARTNERS ADVANCED HEALTHCARE FUND, L.P.

    ARDSLEY DUCKDIVE FUND, L.P.

    • Director
    • 10% Owner
    • SEE FOOTNOTES(1)(2)SEE FOOTNOTES(1)(2)SEE FOOTNOTES(1)(2)SEE FOOTNOTES(1)(2)SEE FOOTNOTES(1)(2)SEE FOOTNOTES(1)(2)SEE FOOTNOTES(1)(2)SEE FOOTNOTES(1)(2)
    15,951,136 2020-12-31 0

    KERCKHOVE GEORGE H

    • Director
    201,841 2020-04-01 0

    OSPRAIE MANAGEMENT, LLC

    OSPRAIE HOLDING I, L.P.

    OSPRAIE MANAGEMENT, INC.

    • Director
    • 10% Owner
    • (SEE REMARKS)(SEE REMARKS)(SEE REMARKS)
    30,666,667 2019-08-07 2

    ARDSLEY ADVISORY PARTNERS LP

    ARDSLEY PARTNERS I

    HEMPLEMAN PHILIP J

    ARDSLEY PARTNERS RENEWABLE ENERGY FUND, L.P.

    ARDSLEY PARTNERS FUND II, L.P.

    ARDSLEY PARTNERS ADVANCED HEALTHCARE FUND, L.P.

    ARDSLEY DUCKDIVE FUND, L.P.

    ARDSLEY HEALTHCARE FUND, L.P.

    • 10% Owner
    • SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)
    0 2019-08-06 0

    OSPRAIE AG SCIENCE LLC

    ANDERSON DWIGHT

    • Director
    • 10% Owner
    • (SEE REMARKS)(SEE REMARKS)
    0 2019-08-06 0

    KERCKHOVE GEORGE H

    KERCKHOVE GEORGE H

    • Director
    0 2019-03-31 0

    VAN HERK INVESTMENTS B.V.

    VAN HERK PRIVATE EQUITY INVESTMENTS B.V.

    VAN HERK MANAGEMENT SERVICES B.V.

    ONROEREND GOED BEHEER- EN BELEGGINGSMAATSCHAPPIJ A. VAN HERK B.V.

    A. VAN HERK HOLDING B.V.

    STICHTING ADMINISTRATIEKANTOOR ABCHRYS

    VAN HERK ADRIANUS

    STICHTING ADMINISTRATIEKANTOOR PENULATA

    • 10% Owner
    No longer subject to file 2019-02-14 0

    ARDSLEY ADVISORY PARTNERS

    ARDSLEY PARTNERS I

    HEMPLEMAN PHILIP J

    ARDSLEY PARTNERS RENEWABLE ENERGY FUND, L.P.

    ARDSLEY PARTNERS FUND II, L.P.

    ARDSLEY PARTNERS ADVANCED HEALTHCARE FUND, L.P.

    ARDSLEY DUCKDIVE FUND, L.P.

    • 10% Owner
    • SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)SEE FOOTNOTE (1)
    10,323,247 2018-08-06 0

    ROMINGER RICHARD E

    • Director
    0 2018-06-30 0

    WADDELL & REED FINANCIAL INC

    WADDELL & REED FINANCIAL SERVICES INC

    WADDELL & REED INC /KS/

    WADDELL & REED INVESTMENT MANAGEMENT CO

    IVY INVESTMENT MANAGEMENT CO

    • 10% Owner
    • 1 & 41 & 41 & 41 & 41 & 4
    49,429,784 2018-02-26 0

    FOGARTY TIMOTHY T

    • Director
    0 2018-01-30 0

    BENOFF MICHAEL H

    • Director
    No longer subject to file 2018-01-30 0

    MERRIGAN KATHLEEN

    • Director
    No longer subject to file 2018-01-30 0

    AHRENS BRIAN R VICE PRESIDENT, SALES

    • Officer
    0 2017-05-21 0

    ARDSLEY ADVISORY PARTNERS

    ARDSLEY PARTNERS I

    HEMPLEMAN PHILIP J

    ARDSLEY PARTNERS RENEWABLE ENERGY FUND, L.P.

    ARDSLEY PARTNERS FUND II, L.P.

    ARDSLEY DUCKDIVE FUND, L.P.

    ARDSLEY PARTNERS INSTITUTIONAL FUND, L.P.

    ARDSLEY PARTNERS ADVANCED HEALTHCARE FUND, L.P.

    • 10% Owner
    3,681,580 2017-04-28 0

    ARDSLEY ADVISORY PARTNERS

    ARDSLEY PARTNERS I

    HEMPLEMAN PHILIP J

    ARDSLEY PARTNERS RENEWABLE ENERGY FUND, L.P.

    ARDSLEY PARTNERS FUND II, L.P.

    ARDSLEY DUCKDIVE FUND, L.P.

    • 10% Owner
    No longer subject to file 2017-04-28 0

    CONTAG PAMELA REILLY

    • Director
    No longer subject to file 2016-05-25 0

    MILLER ELIN D

    • Director
    No longer subject to file 2016-05-25 0

    STANLEY SHAUGN

    • Director
    No longer subject to file 2015-12-17 0

    LYMAN LESLIE F

    • Director
    0 2015-12-17 0

    HOOD NANCY VP MARKETING

    • Officer
    0 2015-12-17 0

    IADEMARCO JAMES NICHOLAS PRESIDENT AND COO

    • Officer
    0 2015-01-14 0

    STEWART ALISON SR VP OF R&D AND CTO

    • Officer
    0 2014-10-03 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 22:15:04 UTC -0.8083 2.3783 5000000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 21:45:03 UTC -0.8083 2.3783 5000000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 21:15:05 UTC -0.8083 2.3783 5000000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 20:45:03 UTC -0.8083 2.3783 5000000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 20:15:04 UTC -0.8083 2.3783 5000000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 19:45:03 UTC -0.8083 2.3783 5000000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 19:15:03 UTC -0.8083 2.3783 5000000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 18:45:03 UTC -0.8083 2.3783 5000000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 18:15:03 UTC -0.8083 2.3783 5000000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 17:45:03 UTC -0.8083 2.3783 5000000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 17:15:03 UTC -0.8083 2.3783 5000000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 16:45:03 UTC -0.8083 2.3783 5000000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 16:15:03 UTC -0.8083 2.3783 5000000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 15:45:03 UTC -0.8083 2.3783 5000000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 15:15:03 UTC -0.8083 2.3783 4900000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 14:45:03 UTC -0.8083 2.3783 4900000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 14:15:04 UTC -0.8083 2.3783 4900000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 13:45:03 UTC -0.8083 2.3783 4900000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 13:15:06 UTC -0.8083 2.3783 1100000
    MARRONE BIO INNOVATIONS INC MBII 2022-07-12 12:45:03 UTC -0.8083 2.3783 1100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments